Behavioral expert Dr. Bill Polonsky on how providers and caregivers can reframe diabetes conversations.
Complications
Higher blood sugar levels cause damage over time to blood vessels and nerves, which can affect your eyes, heart, kidneys, and other organs. It’s important to be aware of these diabetes-related health complications so that you can act now to avoid them or prevent them from progressing.
48 readers recommended
At the Children with Diabetes Friends for Life Conference this month, I had the incredible opportunity to speak to ~100 teenagers with diabetes. My talk, “10 Tips for...
43 readers recommended
Two new large studies investigate Finerenone in type 2 diabetes.
31 readers recommended
A world-renowned researcher’s seven tips for expectant mothers with type 1, type 2, or gestational diabetes
26 readers recommended
Key lessons learned from one woman’s ongoing battle with adrenal insufficiency, and the unexpected role of diabetes technology.
23 readers recommended
New improvements in the second-generation: better battery, app control, and more!
46 readers recommended
Enrolling at over 140 sites worldwide. Can it reduce A1c and insulin use and improve time-in-range?
26 readers recommended
How close is the UN to achieving its goal of “halting the rise in diabetes and obesity” by 2025?
31 readers recommended
FDA expands use to people with mild to moderate kidney disease.
48 readers recommended
People with type 2 diabetes should contact their physicians if symptoms of heart failure appear.
29 readers recommended
Making major improvements over current standard of care – how does this new treatment work? The FDA recently approved a new indication for a product that has been used...
38 readers recommended
People with type 2 diabetes should contact their physicians if they notice new pain, sores, or infections on their legs or feet.
38 readers recommended
FDA Approves New GLP-1 Label on Victoza to show that the medicine makes hearts healthier!
28 readers recommended
Key takeaways from the American Heart Association’s March 2017 conference in Portland, OR
57 readers recommended
Despite neutral heart outcome study results, the FDA added a warning for those at risk of heart failure
34 readers recommended
CVD-REAL study showed SGLT-2 inhibitors reduce the risk of hospitalization for heart failure in over 300,000 people with type 2 diabetes
37 readers recommended
Health Canada has approved the once-daily insulin for adults with type 1 and type 2 diabetes
30 readers recommended
FDA approves Lucentis for all types of diabetic retinopathy and IBM announces a new technology that helps doctors better diagnose retinopathy
36 readers recommended
Instead of “avoid long-term complications,” Adam Brown focuses on something more motivating and uplifting